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tastrointestinal  mixed  adenoneuroendocrine  carcinomas
MANECs)  are  rare  tumors  and,  as  the  name  implies,  are
haracterized  by  the  presence  of  both  components,  exocrine
nd  neuroendocrine,  each  one  representing  at  least  30%  of
he  lesion.1 It  is  unclear  if  they  originate  from  proliferation
f  different  cell  lineages  or  from  stem  cells  capable  of  differ-
ntiating  along  multiple  cell  lineages.  They  may  present  as
olypoid  lesions,  with  variable  size.  Treatment  and  prognosis
s  determined  by  the  more  aggressive  component.2
An  84-year-old  woman  was  referred  to  upper  gastroin-
estinal  endoscopy  for  evaluation  of  dyspepsia.  Endoscopic
xamination  showed  a  15  mm  polypoid  lesion  with  central
lceration  in  the  anterior  wall  of  gastric  body  and  papu-
ous  gastropathy  (Fig.  1).  Biopsies  of  the  gastric  lesion
howed  a  neuroendocrine  tumor  and  random  biopsies  of
he  gastric  mucosa  showed  chronic  atrophic  gastritis  and
ntestinal  metaplasia.  Serum  antibodies  to  parietal  cells  and
o  intrinsic  factor  were  negative.  Serum  level  of  chromo-
ranin  A  level  was  129.6  ng/mL  (normal  level  <  80  ng/mL).
horacic  and  abdominal  CT  revealed  neither  locoregional
denopathies  nor  distant  metastasis.  Single-photon  emis-
ion  computed  tomography  showed  no  lesion  with  uptake
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hat  the  gastric  lesion  was  an  uT1N0  tumor  with  14  ×  7  mm
Fig.  2).  The  gastric  lesion  was  resected  endoscopically  in
ne  fragment  using  the  ‘‘lift  and  cut’’  technique.  Histolog-
cal  examination  of  the  resected  specimen  showed  a  mixed
denoneuroendocrine  carcinoma,  comprising  two  closely
uxtaposed  elements  each  representing  almost  50%  of  the
umor:  (i)  tubular  well-differentiated  adenocarcinoma;  (ii)
euroendocrine  carcinoma  staining  positively  for  chromo-
ranin  A  and  synaptophysin  and  with  a  mitotic  index  higher
han  20  mitoses  per  10  high-power  ﬁelds  (Figs.  3  and  4).  The
umor  invaded  the  submucosa  and  was  intercepted  by  the
eep  and  lateral  margins  of  resection  (Fig.  3) and  so  the
atient  was  proposed  for  surgery.  We  decided  for  laparo-
copic  atypical  gastrectomy  which  has  signiﬁcant  lower  rate
f  complications  than  the  recommended  complete  or  par-
ial  gastrectomy  (en  bloc  resection)  with  local  lymph  node
esection  due  to  patient’s  age  and  poor  performance  sta-
us,  the  low  risk  (11%)  of  lymph  node  metastasis  in  cases  of
umors  with  <2  cm  and  no  extension  into  muscle  on  EUS,3,4
nd  the  absence  of  adenopathies  in  EUS  and  abdominal  CT.
he  surgical  specimen  showed  no  residual  lesion.The  natural  history  of  the  gastric  MANECs  is  unclear,  but  is
ainly  determined  by  the  more  aggressive  component  (the
euroendocrine  component  in  our  case).  Like  the  pure  gas-
ric  neuroendocrine  tumor,  the  prognosis  of  MANEC  depends
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Figure  1  Upper  gastrointestinal  endoscopy  showing  a  15  mm
polypoid  lesion  with  central  ulceration  in  the  anterior  wall  of
gastric body  and  papulous  gastropathy.
Figure  2  Endoscopic  ultrasound  showing  a  hypoechoic  lesion
Figure  3  Histological  examination  (hematoxylin--eosin  stain-
ing; magniﬁcation  20×)  of  the  resected  specimen  showing  a
mixed carcinoma  comprising  a  tubular  well  differentiated  ade-
nocarcinoma  (on  the  right)  and  a  neuroendocrine  carcinoma  (on
the left),  invading  the  submucosa  and  intercepted  by  the  deep
and lateral  margins  of  resection.
Figure  4  Immunohistochemical  staining  with  synaptophysin
(magniﬁcation  20×)  showing  diffuse  positive  staining  by  the
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Aof regular  borders,  with  14  ×  7  mm,  in  the  mucosa  of  gastric
body (uT1N0).
primarily  of  stage  (TNM)  and  also  of  histologic  grading  and
mitotic  count/Ki67  index.  Despite  the  scarce  information
about  this  type  of  cancer,  the  survival  rate  at  ﬁve  years  was
slightly  better  than  pure  gastric  adenocarcinoma,  33.3%  vs
24%  in  one  study.5
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